Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anita Venkitaraman"'
Autor:
Michael Maloney, Carolyne Smith, Anita Venkitaraman, Christian Yee, Miye Jacques, Kelan Hlavaty, Melissa Myint
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/432aba8003874e85af421073ff3a9dd4
Autor:
Matthew G. Booty, Kelan A. Hlavaty, Adam Stockmann, Emrah Ilker Ozay, Carolyne Smith, Lina Tian, Edylle How, Disha Subramanya, Anita Venkitaraman, Christian Yee, Olivia Pryor, Kelly Volk, Katarina Blagovic, Ildefonso Vicente-Suarez, Defne Yarar, Melissa Myint, Amy Merino, Jonathan Chow, Tarek Abdeljawad, Harry An, Sophia Liu, Shirley Mao, Megan Heimann, LeeAnn Talarico, Miye K. Jacques, Eritza Chong, Lucas Pomerance, John T. Gonzalez, Ulrich H. von Andrian, Klavs F. Jensen, Robert Langer, Hendrik Knoetgen, Christine Trumpfheller, Pablo Umaña, Howard Bernstein, Armon Sharei, Scott M. Loughhead
Publikováno v:
The Journal of Immunology. 208:929-940
CD8+ T cell responses are the foundation of the recent clinical success of immunotherapy in oncologic indications. Although checkpoint inhibitors have enhanced the activity of existing CD8+ T cell responses, therapeutic approaches to generate Ag-spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::551c4a24375fe0d38f164f720ccd57bb
https://doi.org/10.4049/jimmunol.2100656
https://doi.org/10.4049/jimmunol.2100656
Autor:
Matthew G, Booty, Kelan A, Hlavaty, Adam, Stockmann, Emrah Ilker, Ozay, Carolyne, Smith, Lina, Tian, Edylle, How, Disha, Subramanya, Anita, Venkitaraman, Christian, Yee, Olivia, Pryor, Kelly, Volk, Katarina, Blagovic, Ildefonso, Vicente-Suarez, Defne, Yarar, Melissa, Myint, Amy, Merino, Jonathan, Chow, Tarek, Abdeljawad, Harry, An, Sophia, Liu, Shirley, Mao, Megan, Heimann, LeeAnn, Talarico, Miye K, Jacques, Eritza, Chong, Lucas, Pomerance, John T, Gonzalez, Ulrich H, von Andrian, Klavs F, Jensen, Robert, Langer, Hendrik, Knoetgen, Christine, Trumpfheller, Pablo, Umaña, Howard, Bernstein, Armon, Sharei, Scott M, Loughhead
Publikováno v:
J Immunol
CD8(+) T cell responses are the foundation of the recent clinical success of immunotherapy in oncologic indications. Although checkpoint inhibitors have enhanced the activity of existing CD8(+) T cell responses, therapeutic approaches to generate Ag-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::61c05f1e7053ee5957f5321dd8d2e325
https://pubmed.ncbi.nlm.nih.gov/35091434
https://pubmed.ncbi.nlm.nih.gov/35091434
Autor:
Miye Jacques, Katherine Seidl, Amritha Ramakrishnan, Christian Yee, Michael F. Maloney, Melissa Myint, Howard Bernstein, Carolyne Smith, Anita Venkitaraman, Scott Loughhead, Armon Sharei, Defne Yarar, Hlavaty Kelan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Antigen-specific CD8+ T cell activity is critical for mounting an effective immune response in a wide range of indications, including immune-oncology and infectious diseases. Methods To elicit antigen-specific CD8+ T cell activity, we used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73760f9047018fc74450a79319f23740
https://doi.org/10.1136/jitc-2020-sitc2020.0169
https://doi.org/10.1136/jitc-2020-sitc2020.0169